Citadel Advisors »

Portage Biotech shares owned by Citadel Advisors

Quarter-by-quarter ownership of Portage Biotech (PRTG) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Portage Biotech

Tip: Access up to 7 years of quarterly data

All positions including Portage Biotech held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Portage Biotech by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $26k 14k 1.80
2023-06-30 $64k 19k 3.42
2022-06-30 $137k 20k 6.98

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Portage Biotech

Lakeview Capital Partners
Ieq Capital
Citadel Advisors
Brown Brothers Harriman & Co.
Beacon Investment Advisory Services
Sigma Planning
Pathstone Holdings
Barclays
Royal Bank of Canada
National Bank Of Canada /fi/
Wells Fargo & Company
CWM
Princeton Global Asset Management
UBS Group

View all funds holding Portage Biotech